MIMI TAN to Helicobacter pylori
This is a "connection" page, showing publications MIMI TAN has written about Helicobacter pylori.
Connection Strength
4.432
-
Controversies in management of Helicobacter pylori infection from a U.S. perspective: population screening and treatment. Minerva Gastroenterol (Torino). 2025 Sep; 71(3):194-206.
Score: 0.489
-
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System. Helicobacter. 2025 Mar-Apr; 30(2):e70034.
Score: 0.476
-
Controversies regarding management of Helicobacter pylori infections. Curr Opin Gastroenterol. 2023 11 01; 39(6):482-489.
Score: 0.429
-
Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution. J Clin Gastroenterol. 2024 May-Jun 01; 58(5):432-439.
Score: 0.425
-
The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1771-1780.
Score: 0.404
-
Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma. Dig Dis Sci. 2023 03; 68(3):761-769.
Score: 0.394
-
Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population. Dig Dis Sci. 2022 09; 67(9):4500-4508.
Score: 0.379
-
Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population. Dig Dis Sci. 2020 08; 65(8):2403-2411.
Score: 0.330
-
Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020. Gastrointest Endosc. 2019 09; 90(3):457-460.
Score: 0.325
-
Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer. BMJ Evid Based Med. 2018 06; 23(3):111-112.
Score: 0.294
-
Evolving Concepts in Helicobacter pylori Management. Gastroenterology. 2024 02; 166(2):267-283.
Score: 0.108
-
Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population. Gastrointest Endosc. 2023 10; 98(4):569-576.e1.
Score: 0.105
-
Ethnicity Is an Important Consideration in Screening for Gastric Intestinal Metaplasia. Dig Dis Sci. 2022 09; 67(9):4509-4517.
Score: 0.096
-
Associations of Duration, Intensity, and Quantity of Smoking With Risk of Gastric Intestinal Metaplasia. J Clin Gastroenterol. 2022 01 01; 56(1):e71-e76.
Score: 0.096
-
Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population. Clin Gastroenterol Hepatol. 2021 02; 19(2):269-276.e3.
Score: 0.084